From a total of 344 female carriers of DMD mutations we identified 24 (7%) patients from 23 unrelated families who presented symptoms associated with dystrophinopathy. This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.